Responses
Clinical and epidemiological research
Extended report
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
Compose a Response to This Article
Other responses
No responses have been published for this article.